KDDF Links With HUYA For Cross-Border R&D Opportunities
This article was originally published in PharmAsia News
Executive Summary
The state-run Korea Drug Development Fund, which provides support to promising new R&D projects at South Korean companies, has begun to explore additional opportunities to bring in innovative drug compounds from overseas to prop up South Korean pharmas’ pipelines, amid the country's ongoing efforts to become a developer of novel global drugs.